News Breaks |
|
|
| November 26, 2012 |
| 07:26 EDT |  | ILMN, RHHBY | Illumina downgraded to Neutral from Outperform at RW Baird
RW Baird downgraded Ilumina as the firm believes that the outlook for the company's partnership with BGI has been clouded, and notes that a potential takeover of Ilumina by Roche (RHHBY) fell through previously. Target $54. |
|
|
News For ILMN;RHHBY From The Last 14 Days Check below for free stories on ILMN;RHHBY the last two weeks. |
|
|
| May 23, 2013 |
| 15:19 EDT |  | RHHBY | FDA announces approval of Roche diabetes test
 Subscribe for More Information |
|
| May 22, 2013 |
| 10:33 EDT |  | RHHBY | Bristol-Myers jumps after Citi ups rating on cancer potential
Subscribe for More Information |
|
| 10:00 EDT |  | RHHBY | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 06:02 EDT | | RHHBY | Roche upgraded to Buy from Neutral at Citigroup
Subscribe for More Information |
|
| May 21, 2013 |
| 20:03 EDT |  | RHHBY | Roche, Sigma-Aldrich teamed for Life bid, Reuters says
Subscribe for More Information |
|
| May 20, 2013 |
| 17:26 EDT | | RHHBY | Regeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information |
|
| 17:20 EDT | | RHHBY | Regeneron,, Bayer, Genentech resolve certain patent disputes
Subscribe for More Information |
|
| 14:06 EDT | | ILMN | Illumina says Verinata reimbursements exceeding expectations
At the UBS Healthcare Conference earlier today, Illumina (ILMN) CFO Marc Stapley said adoption for the company's Verinata prenatal test has met expectations, while reimbursement for the test has exceeded expectations, adding that its relationship with PerkinElmer (PKI) has allowed the company to obtain significant coverage decisions. In afternoon trading, shares of Illumina are up $1.48, or 2.06%, to $73.48. |
|
| May 17, 2013 |
| 11:59 EDT |  | ILMN | Options with decreasing implied volatility: ILMN LO A HES INFY CSCO
|
|
| 11:39 EDT | | ILMN | High option volume stocks: GNK VNDA BYI ARUN BYI ILMN
Subscribe for More Information |
| |
| May 15, 2013 |
| 17:26 EDT | | ILMN | Third Point gives quarterly update on stakes
NEW STAKES: Virgin Media (VMED), Tiffany (TIF), B/E Aerospace (BEAV), Anadarko (APC), and Thermo Fisher (TMO). INCREASED STAKES: International Paper (IP), Abbvie (ABBV), TransDigm (TDG), Constellation Brands (STZ), and Dollar General (DG). DECREASED STAKES: Delphi (DLPH), Murphy Oil (MUR), AIG (AIG), LyondellBasell (LYB), and Liberty Global (LBTYA). LIQUIDATED STAKES: Tesoro (TSO), Morgan Stanley (MS), Symantec (SYMC), Herbalife (HLF), and Illumina (ILMN). |
|
| 15:59 EDT | | RHHBY | Roche exploring sale of blood glucose meters unit, Reuters says
Subscribe for More Information |
|
| 12:13 EDT |  | RHHBY | Roche management to meet with Jefferies
Meeting to be held in London on May 17 hosted by Jefferies. |
|
| 11:38 EDT | | RHHBY | Roche says FDA approves Tarceva tablets for specific lung cancer situation
Subscribe for More Information |
|
| 06:36 EDT | | ILMN | Illumina to partner for automation of sample preparation kits
Subscribe for More Information |
|
| May 14, 2013 |
| 16:55 EDT | | RHHBY | FDA approves Roche's cobas EGFR mutation test with Tarceva
Subscribe for More Information |
|
| 10:24 EDT | | ILMN | Illumina management to meet with JPMorgan
Subscribe for More Information |
|
| May 13, 2013 |
| 08:55 EDT | | RHHBY | Biosimiliar drug bill to be taken up in Senate, LA Times reports
Subscribe for More Information |
|
| 07:30 EDT | | RHHBY | TechConnect to host a summit
2013 National Innovation Summit is being held in Washington, D.C. on May 12-16. |
|
| May 10, 2013 |
| 15:59 EDT | | RHHBY, ILMN | Roche spokesman reiterates that Illumina is "off the table," Bloomberg reports
Subscribe for More Information |
| |
|
|
|
|
